Functional cure based on pegylated interferon alpha therapy in nucleoside analog-suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest Project in China)-3.5 years data update
第一作者机构:[1]Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714):
Xie Chan,Xie Dongying,Fu Lei,et al.Functional cure based on pegylated interferon alpha therapy in nucleoside analog-suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest Project in China)-3.5 years data update[J].JOURNAL OF HEPATOLOGY.2022,77:S838-S838.
APA:
Xie, Chan,Xie, Dongying,Fu, Lei,Zhang, Wen-hua,Wei, Jia...&Gao, Zhiliang.(2022).Functional cure based on pegylated interferon alpha therapy in nucleoside analog-suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest Project in China)-3.5 years data update.JOURNAL OF HEPATOLOGY,77,
MLA:
Xie, Chan,et al."Functional cure based on pegylated interferon alpha therapy in nucleoside analog-suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest Project in China)-3.5 years data update".JOURNAL OF HEPATOLOGY 77.(2022):S838-S838